InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,713.60
(
0.18%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
83.21
(
1.00%
)
Bitcoin
62,781.71
(
2.17%
)
Post# of 640541
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

zigzagman

Send PM Follow Ignore
Followers 646
Posts 144549
Boards Moderated 1
Alias Born 05/19/2007

zigzagman

Re: None

Thursday, 12/08/2016 3:29:09 PM

Thursday, December 08, 2016 3:29:09 PM

Post# of 640541
$ENTB's primary goal is to continue growing the number of Veterinary Hospitals we own, stated Dr. David Koos, Chairman and CEO of Entest BioMedical. "In pursuing this segment of our business model, we will be able to continue growing our asset base, increase our current revenue stream and establish an initial distribution channel for our products and therapies; the first of these products being Entest's ImenVax immune-therapeutic canine cancer vaccine currently under development.

https://www.yahoo.com/news/entest-biomedical-inc-sees-entry-124500670.html

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up